论文部分内容阅读
目的探讨痰热清辅助治疗慢性阻塞性肺疾病(COPD)急性加重期的临床疗效。方法将92例COPD急性加重期患者随机分为两组各46例,对照组给予头孢哌酮钠舒巴坦钠及西药常规对症治疗,观察组联合给予中药痰热清治疗,1个疗程后对比两组疗效。结果观察组总有效率优于对照组,中医症候评分及FEV1均较对照组改善更为明显,差异有统计学意义(P<0.05)。结论痰热清辅助治疗COPD急性加重期患者可促进病情缓解,提高临床疗效,改善患者预后。
Objective To investigate the clinical efficacy of Tanreqing adjuvant in the treatment of acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods 92 patients with acute exacerbation of COPD were randomly divided into two groups of 46 cases, the control group was given cefoperazone sodium and sulbactam sodium and western medicine symptomatic treatment, the observation group combined with traditional Chinese medicine Tanreqing treatment, a course of treatment after two groups of curative effect . Results The total effective rate in the observation group was better than that in the control group. The TCM symptom scores and FEV1 were more obvious than those in the control group, with significant difference (P <0.05). Conclusion Tanreqing adjuvant treatment of acute exacerbation of COPD patients can promote the remission, improve clinical efficacy and improve prognosis.